Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Stock Statistics & Valuation Metrics

Xuanzhu Biopharmaceutical Co., Ltd. Class H has a market cap or net worth of HKD 4.45B. The enterprise value is HKD 6.24B.

Market Cap

HKD 4.45B

Enterprise Value

HKD 6.24B

Xuanzhu Biopharmaceutical Co., Ltd. Class H has 517,947,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

517,947,800

Owned by Insiders

―

Owned by Institutions

0.02%

Xuanzhu Biopharmaceutical Co., Ltd. Class H’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -16.01%.

Return on Equity (ROE)

-0.17

Return on Assets (ROA)

-0.15

Return on Invested Capital (ROIC)

-16.01%

Return on Capital Employed (ROCE)

-0.16

Revenue Per Employee

163.22K

Profits Per Employee

-774.01K

Employee Count

344

Asset Turnover

0.03

Inventory Turnover

0.36

The current PE Ratio of Xuanzhu Biopharmaceutical Co., Ltd. Class H is -16.22. Xuanzhu Biopharmaceutical Co., Ltd. Class H’s PEG ratio is -0.14.

PE Ratio

-16.22

PS Ratio

34.24

PB Ratio

2.68

Price to FCF

-18.67

Price to Operating Cash Flow

-18.75

PEG Ratio

-0.14

In the last 12 months, Xuanzhu Biopharmaceutical Co., Ltd. Class H had revenue of 56.15M and earned -266.26M in profits. Earnings per share was -0.51.

Revenue

56.15M

Gross Profit

21.80M

Operating Income

-253.14M

Pretax Income

-266.25M

Net Income

-266.26M

EBITDA

-220.55M

Earnings Per Share (EPS)

-0.51

In the last 12 months, operating cash flow was -213.58M and capital expenditures -876,939, giving a free cash flow of -214.45M billion.

Operating Cash Flow

-213.58M

Free Cash Flow

-214.45M

Free Cash Flow per Share

-0.41

Xuanzhu Biopharmaceutical Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-5.36%

Earnings Yield

-5.86%

Beta

2.12

52-Week Price Change

-87.85%

50-Day Moving Average

8.98

200-Day Moving Average

24.96

Relative Strength Index (RSI)

35.43

Average Volume (3m)

2.00M

Xuanzhu Biopharmaceutical Co., Ltd. Class H upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date

Aug 26, 2026

Next Earnings Date

―

Ex-Dividend Date

―

Xuanzhu Biopharmaceutical Co., Ltd. Class H as a current ratio of 3.75, with Debt / Equity ratio of 0.05%

Current Ratio

3.75

Quick Ratio

3.36

Debt to Market Cap

0.00

Net Debt to EBITDA

3.47

Interest Coverage Ratio

-1882.37

In the past 12 months, Xuanzhu Biopharmaceutical Co., Ltd. Class H has paid 6,507 in taxes.

Income Tax

6,507

Effective Tax Rate

-0.00

Xuanzhu Biopharmaceutical Co., Ltd. Class H EV to EBITDA ratio is -18.40, with an EV/FCF ratio of -15.93.

EV to Sales

29.22

EV to EBITDA

-18.40

EV to Free Cash Flow

-15.93

EV to Operating Cash Flow

-16.00

Xuanzhu Biopharmaceutical Co., Ltd. Class H has HKD 587.30M in cash and marketable securities with HKD 251.80K in debt, giving a net cash position of HKD 587.05M billion.

Cash & Marketable Securities

HKD 587.30M

Total Debt

HKD 251.80K

Net Cash

HKD 587.05M

Net Cash Per Share

HKD 1.13

Tangible Book Value Per Share

HKD 1.37

Gross margin is 34.41%, with operating margin of -182.18%, and net profit margin of -200.78%.

Gross Margin

34.41%

Operating Margin

-182.18%

Pretax Margin

-200.78%

Net Profit Margin

-200.78%

EBITDA Margin

-158.82%

EBIT Margin

-189.09%

The average price target for Xuanzhu Biopharmaceutical Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

237.19%

EPS Growth Forecast

61.28%

Smart Score

1

AI Score

48